| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |